ARPA-H: Systematic Targeting Of MicroPlastics (STOMP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

ARPA-H’s Systematic Targeting Of MicroPlastics (STOMP) program is a new funding opportunity focused on detecting, understanding, and ultimately removing toxic microplastics from the human body. This is an early-stage, high-impact program targeting a major and unresolved public health challenge.

To apply, you must first submit a required Solution Summary by Monday, May 6, 2026, 5:00PM ET. Only those encouraged will proceed to a full proposal due Monday, June 22, 2026, 5:00PM ET. These deadlines are firm but noted as subject to change—waiting risks missing your window.

STOMP will fund efforts in measurement and biological understanding now, with removal technologies expected in a later phase.

How much funding would I receive?

Funding is expected to range from $500k - $10m.

What could I use the funding for?

Funding supports R&D aligned with two primary technical areas:

Phase 1:

• Develop lab-based measurement tools for nano-sized microplastics in biological tissue

• Image and characterize microplastics in organs and cells

• Study mechanisms of microplastic trafficking and toxicity

Phase 2:

• Translate measurement methods into scalable clinical systems

• Develop solutions to remove microplastics from the human body

Are there any additional benefits I would receive?

• Access to a multidisciplinary ARPA-H program environment

• Opportunity to collaborate across technical domains

• Participation in a program aimed at major healthcare impact

No additional non-dilutive benefits (e.g., commercialization support, follow-on funding) are specified in the solicitation.

What is the timeline to apply and when would I receive funding?

Key Dates:

• Solution Summary Due: Monday, May 6, 2026, 5:00PM ET

• Full Proposal Due: Monday, June 22, 2026, 5:00PM ET

Additional notes:

• A Solution Summary is required to submit a full proposal

• Proposers will be encouraged or discouraged from submitting a full proposal after summary review

• Dates are stated as estimates and subject to change

Award timing:

• Not specified in the solicitation

Where does this funding come from?

• Advanced Research Projects Agency for Health (ARPA-H)

• Notice ID: ARPA-H-SOL-26-152

Who is eligible to apply?

• Eligibility criteria are not specified in the provided materials

What companies and projects are likely to win?

Based on stated program goals, competitive proposals will likely:

• Focus on microplastics measurement technologies or biological mechanism understanding

• Address challenges in detecting nano-sized particles in complex biological systems

• Provide novel approaches to understanding toxicity and distribution in the body

• Demonstrate strong multidisciplinary teaming, as teaming is encouraged

• Align with future translation into clinical and scalable systems

Are there any restrictions I should know about?

• A Solution Summary is required before submitting a full proposal

• Full proposals are recommended only for those encouraged to proceed

• Specific restrictions (e.g., cost share, IP terms, or use of funds) are not specified in the provided materials

How long will it take me to prepare an application?

• Not specified in the solicitation

However:

• The two-step process (Solution Summary → Full Proposal) requires staged preparation

• Teaming is encouraged, which may increase coordination time

How can BW&CO help?

BW&CO can support:

• Interpreting ARPA-H program fit and positioning

• Drafting compelling Solution Summaries aligned to evaluation criteria

• Structuring full proposals for technical clarity and competitiveness

• Coordinating multi-partner teams and narrative cohesion

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

Golden Dome for America - Department of War CSO

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Office of the Secretary of War (Golden Dome for America) is seeking innovative commercial technologies, services, and capabilities to defend the U.S. homeland against advanced threats including ballistic missiles, hypersonics, cruise missiles, and other aerial systems. This is a long-term, continuously open Commercial Solutions Opening (CSO) designed to rapidly fund and deploy breakthrough solutions using flexible contracting.

This opportunity is open from the date of CSO posting through 30 September 2035. There is no single deadline—submissions can be made on a rolling basis, and additional Calls may define specific due dates.

How much funding would I receive?

Funding is expected to range from $500k - $10m.

• There is no restriction on the number, type, value, or frequency of awards

• Awards may vary widely in scope, duration, and price

• The Government may fund all, part, or none of any submission

• Awards may be incrementally funded at the Government’s discretion

What could I use the funding for?

Funding can be used to support:

• Prototype projects directly relevant to DoD systems, platforms, components, or materials

• Development of innovative commercial technologies and services

• Solutions that:

  • Close capability gaps

  • Accelerate mission effectiveness

  • Introduce breakthrough technological advancements

The program prioritizes:

• Rapid testing and proof-of-concept efforts

• Technologies addressing urgent and complex threats

• Applications that significantly improve or transform existing capabilities

Are there any additional benefits I would receive?

Yes. This CSO provides:

• Access to Other Transaction (OT) agreements and FAR-based contracts

• Opportunity for follow-on prototype or production agreements

• Flexible acquisition pathways using streamlined procedures

• Ability to collaborate at higher security levels when required

• Potential for one-step awards directly from white papers

What is the timeline to apply and when would I receive funding?

• The CSO is open from the date of CSO posting through 30 September 2035

• White papers may be submitted at any time during this period

• Specific deadlines will only be provided in individual Calls or RFPs

• Submissions close to the end of the CSO period may not be reviewed in time

Timing for funding decisions is not specified, but:

• Reviews are intended to be streamlined and expedient

• The Government may communicate for clarification during evaluation

• Awards may be made directly from white papers or after an RFP process

Where does this funding come from?

Funding comes from:

• Office of the Secretary of War (Golden Dome for America)

Authorized under:

• DFARS 212.70 – Commercial Solutions Opening

• 10 USC 4022 (Other Transaction Authority)

• 10 USC 3458 (Commercial acquisition authority)

Who is eligible to apply?

Eligible applicants include:

• All sources capable of addressing the objectives of the CSO

• Traditional defense contractors

• Nontraditional defense contractors

• Non-profit research institutions

Applicants must comply with:

• Applicable security requirements

• Conflict of interest disclosures

Note: Entities providing SETA or similar support to GDA may not simultaneously act as performers without prior approval.

What companies and projects are likely to win?

The Government prioritizes:

• Breakthrough technologies over incremental improvements

• Solutions that address urgent and high-priority mission needs

• Proposals that enable:

  • Rapid testing

  • Proof-of-concept demonstrations

  • Accelerated deployment

Evaluation is based on:

• Technical merit

• Price (must be fair and reasonable)

• Overall value relative to mission impact and portfolio balance

Are there any restrictions I should know about?

Yes. Key restrictions include:

• White papers:

  • Must not exceed 10 pages

• Proposals (if requested):

  • Technical volume: max 20 pages

  • Price volume: max 10 pages

• Submissions must:

  • Be in English

  • Meet security requirements

  • Properly mark proprietary information

Additional constraints:

• The Government may:

  • Modify scope, price, or terms

  • Use one-step or two-step evaluation processes

  • Select partial proposals

How long will it take me to prepare an application?

• White papers are designed to be uncomplicated and limited to 10 pages

• A one-step award may be possible if sufficient detail is included

• Additional effort may be required if invited to submit a full proposal

How can BW&CO help?

BW&CO can support you by:

• Identifying where your technology aligns with GDA mission priorities

• Developing a compliant, high-impact white paper

• Structuring your submission for one-step award consideration

• Positioning your solution as a breakthrough capability

• Supporting follow-on proposals if an RFP is issued

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

CDMRP: Peer Reviewed Medical Research Program (PRMRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Peer Reviewed Medical Research Program (PRMRP) is a pre-announcement from the Department of Defense indicating substantial upcoming funding across a wide range of medical research topics relevant to military health. This is an early signal to begin preparing—applications are not yet open, and deadlines are not specified in this pre-announcement. Once released on Grants.gov, these opportunities will move quickly and require pre-applications or letters of intent.

This program supports everything from early-stage discovery through large-scale clinical trials, with awards ranging from $385,000 up to $20M+ depending on mechanism. Founders and research teams should begin aligning projects now to be competitive when announcements drop.

Pre-Applications are due on 7/16/26 and 7/23/26.

Full Applications are due between 7/30/26 and 9/22/26.

How much funding would I receive?

Funding varies significantly by award mechanism:

• Clinical Trial Award

  • Planning Phase: up to $800,000

  • Level 1: up to $6M

  • Level 2: up to $10M

  • Level 3: up to $20M

• Discovery Award

  • Up to $385,000

• Impact Award

  • Single PI: up to $2.8M

  • Partnering PI: up to $3.6M

• Lifestyle and Applied Health Research Award

  • Up to $4.2M

• Platform Clinical Translation Award

  • Up to $15M (with only $8M guaranteed from FY26 funds)

• Research Advancement Award

  • Up to $1.4M

• Technology/Therapeutic Development Award

  • Up to $5.6M

All amounts are total costs (direct + indirect).

What could I use the funding for?

Funding supports a broad spectrum of medical research aligned to congressionally mandated topic areas, including (not exhaustive):

• PTSD, traumatic brain injury, suicide prevention

• Burn pit exposure, respiratory health

• Rare diseases (e.g., Rett Syndrome, Fragile X, mitochondrial disease)

• Chronic conditions (e.g., diabetes-related areas not explicitly listed, IBD, fibromyalgia-related analogs where applicable)

• Women’s health (e.g., endometriosis, maternal mental health)

• Neurological and musculoskeletal conditions

Use cases depend on the mechanism:

• Discovery Award: High-risk, early-stage concepts (no preliminary data)

• Impact Award: Hypothesis-driven work with preliminary data

• Clinical Trial Award: Phase 0–3 trials

• Technology/Therapeutic Development: Translating preclinical work into products

• Platform Clinical Translation: Multi-indication platforms

• Lifestyle and Applied Health: Quality of life, behavioral, and applied interventions

Projects must align to at least one specified topic area.

Are there any additional benefits I would receive?

• Validation from the Department of Defense and CDMRP

• Access to non-dilutive capital at scale (up to $20M)

• Opportunity to support military-relevant health outcomes

• Structured pathways for clinical translation and regulatory readiness (e.g., IND/IDE planning support under Clinical Trial Award)

Additional benefits are not further specified in the pre-announcement.

What is the timeline to apply and when would I receive funding?

• Pre-Applications are due on 7/16/26 and 7/23/26.

• Full Applications are due between 7/30/26 and 9/22/26.

• Submission will require:

  • Pre-application (e.g., preproposal or letter of intent depending on mechanism)

  • Full application (often by invitation only)

• Periods of performance:

  • Range from 2 years to 4 years depending on mechanism

  • Planning phases up to 18 months

Exact award start timelines are not specified.

Where does this funding come from?

• FY26 Defense Appropriations Act

• Administered by:

  • Defense Health Agency (DHA) Research and Development

  • Medical Research and Development Command (MRDC)

  • Managed through the Congressionally Directed Medical Research Programs (CDMRP)

Who is eligible to apply?

• Independent investigators at all career levels

• Applies across all award mechanisms

No additional institutional, geographic, or organizational eligibility restrictions are specified in this pre-announcement.

What companies and projects are likely to win?

Based strictly on the solicitation:

• Projects that:

  • Align directly with congressionally mandated topic areas

  • Demonstrate clear relevance to military health

  • Show high impact and scientific merit

• Competitive profiles by mechanism:

  • Discovery: Bold, untested ideas without preliminary data

  • Impact: Strong preliminary data + near-term impact potential

  • Clinical Trial: Well-developed interventions ready for human testing

  • Technology/Therapeutic Development: Clear product-oriented outcomes

  • Platform Clinical Translation: Solutions addressing multiple topic areas

• Teams:

  • May include clinician researchers or industry partners (required in some partnering options)

Further selection criteria are not specified in this pre-announcement.

Are there any restrictions I should know about?

Key restrictions vary by mechanism:

• Clinical Trial Award

  • Cannot support preclinical research

  • Requires regulatory approvals (e.g., IND/IDE) where applicable

• Discovery Award

  • Cannot include preliminary data

  • Cannot support clinical trials

• Impact Award

  • Cannot support clinical trials

• Lifestyle and Applied Health Research Award

  • Cannot support animal studies

• Technology/Therapeutic Development Award

  • Cannot support clinical trials

• Research Advancement Award

  • Cannot support clinical trials

• All applications:

  • Must align to specified topic areas

  • Require pre-application submission (preproposal or LOI depending on mechanism)

How long will it take me to prepare an application?

Not explicitly specified, but based on required steps:

• Pre-application required (LOI or preproposal)

• Full applications often by invitation only

• Clinical trial applications may require:

  • Regulatory documentation (e.g., IND/IDE)

Exact preparation timelines are not specified in the pre-announcement.

How can BW&CO help?

BW&CO can support:

• Opportunity qualification against PRMRP mechanisms

• Topic area alignment and positioning

• Preproposal / LOI development

• Full application strategy and narrative development

• Clinical and product translation positioning

• Partnering strategy (e.g., clinician or industry PI alignment)

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

CDMRP: Combat Readiness–Medical Research Program (CRRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Combat Readiness–Medical Research Program (CRRP) will fund innovative, high-impact research to improve Warfighter survivability and readiness, with a focus on trauma care and operational medical capabilities. This is a pre-announcement, giving advance notice so teams can prepare—the full funding opportunity with required deadlines has not yet been released.

Critically, application deadlines are not specified in this pre-announcement. Once released, the solicitation will include required pre-application and full application deadlines. Teams should begin preparing now, as this program uses a pre-application screening process with invitation-only full submissions.

How much funding would I receive?

• Maximum total funding: $2.45 million (total costs)

• Guaranteed funding from FY26: $1.45 million

• Remaining funding supports optional research efforts

• Period of performance:

  • Maximum total: 3 years

  • Base period: 2 years

  • Optional period: 1 year

What could I use the funding for?

Funding supports translational research in combat casualty care, including:

• Battlefield diagnostics, triage, and decision support tools

• Treatments to improve care delivery in:

  • Point of injury

  • Austere surgical/resuscitative environments

  • Prolonged casualty care

  • En route care

• Battlefield readiness solutions focused on pre-hospital and operational environments

Projects must be hypothesis-driven and supported by preliminary data and aim to move promising technologies toward real-world trauma care solutions.

Are there any additional benefits I would receive?

• Not specified in the pre-announcement.

What is the timeline to apply and when would I receive funding?

• This is a pre-announcement only

• The full funding opportunity will be posted on Grants.gov

• Pre-application submission is required via eBRAP

• Full applications are by invitation only

Application deadlines are not specified in this pre-announcement and will be provided when the official solicitation is released.

Where does this funding come from?

• FY26 Defense Appropriations Act

• Managed by:

  • Congressionally Directed Medical Research Programs (CDMRP)

  • Under the Defense Health Agency (DHA) Research and Development – Medical Research and Development Command (MRDC)

Who is eligible to apply?

• Independent Investigators at all academic levels, or equivalent

No additional eligibility restrictions are specified.

What companies and projects are likely to win?

Projects most aligned with the program’s intent will:

• Address combat casualty care and operational medical challenges

• Demonstrate strong preliminary data

• Be translational—moving technologies toward real-world use

• Show potential to:

  • Improve survivability

  • Enable care closer to the point of injury

  • Inform trauma care guidelines

Are there any restrictions I should know about?

• Pre-application is required; full submission is invitation-only

• Applications must include preliminary data

• Research may include:

  • Animal models (allowed, not required)

  • Clinical research (allowed, not required)

  • Small-scale pilot clinical trials (optional, within performance period)

• Applications must conform to the final FOA once released

How long will it take me to prepare an application?

Not specified in the pre-announcement.

However, given the pre-application + invitation-only structure and requirement for preliminary data, teams should expect a multi-phase process and begin preparation early.

How can BW&CO help?

BW&CO can support across the full lifecycle:

• Positioning your technology against CRRP focus areas

• Developing a competitive pre-application strategy

• Translating technical work into clear, reviewer-aligned narratives

• Building a data-driven commercialization and impact story

• Managing submission through eBRAP and Grants.gov workflows

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Project Development and Supply Chain Reimbursement Program (PDSCRP) – Texas Advanced Nuclear Energy Office (TANEO)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Texas Advanced Nuclear Energy Office is awarding up to $70 million to businesses, nonprofits, and government entities for advanced nuclear project development and supply chain activities in Texas. Opportunities available for both Texas and Non-Texas based companies. Individual awards cover up to 50% of costs or $12.5M. Notice of Intent to apply Due April 23, 2026. Full applications are due May 14, 2026.

How much funding would I receive?

Individual awards are capped at the lesser of:

• 50% of qualifying project expenses

• $12.5 million

What could I use the funding for?

Funding supports reimbursement for expenses related to:

• technology development, including university technology development

• feasibility studies

• site planning, including conceptual site-specific engineering studies

• front-end engineering design

• site and environmental characterization

• Nuclear Regulatory Commission (NRC) early site permit work

• preparation of the construction permit or license application to the NRC commission

• developing manufacturing capacity and readiness

• fuel processing, manufacturing, and fabrication activities essential to the fuel cycle supply

• preparation of local, state, and non-NRC federal permits

• NRC licensing fees

Are there any additional benefits I would receive?

Beyond reimbursement funding, recipients benefit from:

• State-Level Validation: Selection by TANEO signals alignment with Texas’ strategic nuclear energy priorities, which strengthens credibility with regulators, utilities, and investors.

• Access to Texas Energy Ecosystem: Projects integrate into a statewide push to expand advanced nuclear infrastructure, enabling partnerships across manufacturing, academia, and energy providers.

• Workforce and Supply Chain Positioning: Awardees gain early positioning in a developing nuclear supply chain ecosystem, which can unlock long-term contracts and industrial partnerships.

• Stronger Financing Position: Demonstrating partial cost coverage and state backing improves capital stack viability and reduces perceived project risk for private investors.

What is the timeline to apply and when would I receive funding?

• Notice of Intent to Apply: April 23, 2026

• Application Deadline: May 14, 2026

• Grant Selections: Week of July 20, 2026

• Period of Performance Begins: Week of September 14, 2026

Where does this funding come from?

Funding comes from the Texas Advanced Nuclear Development Fund (TANDF), administered by the Texas Advanced Nuclear Energy Office.

Who is eligible to apply?

Eligible applicants include:

• Businesses

• Nonprofit organizations

• Governmental entities (including institutions of higher education)

What companies and projects are likely to win?

Applications are evaluated based on:

• Project feasibility, readiness, and regulatory status

• Economic development impact including job creation and supply chain growth

• Strength of financing plan and cost-effectiveness

• Organizational capability and relevant experience

• Project completion viability and long-term impact in Texas

Are there any restrictions I should know about?

• Only expenses incurred after grant execution are eligible for reimbursement

• Expenses funded by other government sources are not eligible as matching funds

• A Notice of Intent to Apply is mandatory

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($300 an hour) and full engagements (Initial Fee quoted upon request + 3-5% Success Fee)

Additional Resources

Review the solicitation here.

Engage SOF (eSOF) Capabilities of Interest – U.S. Special Operations Command (USSOCOM)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

USSOCOM’s Engage SOF (eSOF) program provides a rolling pathway for companies to submit technologies aligned with Special Operations Forces (SOF) capability needs. Selected solutions may receive funding through contracts, OTAs, SBIR/STTR, or other mechanisms. Submissions are open through December 31, 2026.

How much funding would I receive?

Estimated $500K to $5 Million - Funding is not fixed. Awards vary depending on the pathway and may include contracts, OTAs, SBIR/STTR, CRADAs, or prize competitions.

What could I use the funding for?

Projects must align with USSOCOM Capabilities of Interest (CoIs), including (full list here):

• Aviation Systems

• Biometrics and Forensics

• Command, Control, Communications, and Computers (C4)

• Cyberspace Operations

• Human Performance/Human Machine Interface

• Information Operations

• Intelligence, Surveillance, and Reconnaissance (ISR)

• Irregular Warfare

• Medical Technology

• Canine Medicine

• Mobility

• Power and Energy

• Soldier Systems

• Weapons and Electronic Attack

Are there any additional benefits I would receive?

Beyond direct funding, there are significant indirect benefits:

Government Validation and Credibility: Selection by USSOCOM signals strong alignment with real-world defense needs and increases trust with DoD stakeholders, primes, and investors.

Direct Access to End Users: eSOF connects companies directly with Program Executive Offices, Directorates, and operators for real-world feedback and validation.

Multiple Contracting Pathways: Companies can transition into OTAs, FAR contracts, CRADAs, or prototype programs without starting from scratch.

Follow-on Opportunities: Successful technologies may progress into experimentation, prototyping, and eventual procurement pathways.

Stronger Exit Potential: Government-backed validation and nondilutive funding can significantly increase company valuation and acquisition interest.

What is the timeline to apply and when would I receive funding?

Submissions are accepted on a rolling basis from March 26, 2026 through December 31, 2026.

Funding timing varies depending on the pathway and evaluation process after submission.

Where does this funding come from?

Funding comes from U.S. Special Operations Command (USSOCOM) and is executed through various federal acquisition and research mechanisms including OTAs, FAR contracts, SBIR/STTR, and others.

Who is eligible to apply?

Any organization capable of providing relevant commercial technologies may apply. Submissions must present unclassified information and align with published Capabilities of Interest.

What companies and projects are likely to win?

• Clearly match one or more published Capabilities of Interest

• Demonstrate strong technical maturity and real-world applicability

• Show measurable impact on SOF mission effectiveness

• Meet security and compliance requirements

• Provide evidence supporting performance and readiness

Are there any restrictions I should know about?

• Submissions must be UNCLASSIFIED

• Solutions must align with current Capabilities of Interest to be prioritized

• May require CMMC compliance and security vetting

• Some pathways may involve classified applications and facility clearance requirements

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available (Only $4,000 for preliminary application).

Additional Resources

Review the solicitation here (Requires Login).

Product Development Funding Programs – Cancer Prevention and Research Institute of Texas (CPRIT)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

CPRIT provides flexible, non-dilutive funding to support the development and commercialization of innovative cancer technologies. Through four distinct programs—SEED, TDDC, TTC, and TNTC—CPRIT funds companies across the full lifecycle, from early-stage discovery to late-stage clinical development. Preliminary applications are due April 16, 2026, with full applications due July 9, 2026.

How much funding would I receive?

Funding varies by program:

• SEED Awards: Up to ~$3 million (early-stage)

• TDDC, TTC, TNTC: No fixed cap; funding is flexible and negotiated based on project scope

CPRIT allocates approximately $70 million annually for company investments and distributes funding through milestone-based contracts tied to project progress

What could I use the funding for?

Funding supports research and development of technologies for the prevention, detection, diagnosis, monitoring, and treatment of cancer.

Common use cases include:

• Artificial intelligence and bioinformatics

• Therapeutics (drugs, biologics, cell therapies)

• Diagnostics and medical devices

• Manufacturing and biomanufacturing

• Clinical validation and trials

• Sample quality improvement and research tools

Which CPRIT Program is right for me?

CPRIT offers four programs designed for different stages and technology types:

SEED Awards (Earliest Stage)

• Focus: Preclinical and company formation

• Stage: Discovery → proof-of-concept

• Goal: De-risk early science and make the company investable

• Funding: Up to ~$3M

TDDC (Texas Diagnostic & Device Company Awards)

• Focus: Diagnostics and medical devices

• Stage: Late-stage development (near regulatory submission)

• Goal: Advance toward commercialization and market entry

TTC (Texas Therapeutics Company Awards)

• Focus: Therapeutics (drugs, biologics, cell therapies)

• Stage: IND-enabling through clinical development

• Goal: Advance clinical programs and regulatory approval

TNTC (Texas New Technologies Company Awards)

• Focus: Emerging and non-traditional technologies

• Stage: Varies

• Examples: AI, platforms, research tools, enabling technologies

• Goal: Support innovations that do not fit neatly into therapeutics or devices

What is the application process?

All CPRIT programs follow the same two-stage, competitive process:

Stage 1: Preliminary Application (Initial Screening)
Applicants submit:

• Abstract

• Executive summary (≤2 pages)

• Slide deck (≤16 slides)

• Project aims and budget

Applications are reviewed for scientific merit and alignment with CPRIT priorities. Only top applicants are invited to proceed.

Stage 2: Full Application (Deep Diligence)
Invited companies submit:

• Integrated product development plan (technical, clinical, regulatory)

• Full business plan (market, competition, commercialization, financials, IP)

• Timeline and milestones

• Management team and execution plan

Applicants present to an expert panel and undergo due diligence before final selection.

Final Decision Process

• Scientific and product review

• Due diligence

• Program Integration Committee review

• Final approval by CPRIT Oversight Committee

Funding is awarded via milestone-based contracts tied to performance.

What is the timeline to apply and when would I receive funding?

• Preliminary Application Opens: April 7, 2026

• Preliminary Application Deadline: April 16, 2026

• Full Application Invitation: June 2026

• Full Application Deadline: July 9, 2026

• Award Period: September 1, 2026 – August 31, 2027

Funding is deployed over multiple years based on milestone completion.

Where does this funding come from?

Funding is provided by CPRIT through $6 billion in Texas taxpayer-backed general obligation bonds dedicated to cancer research and commercialization.

Who is eligible to apply?

Applicants must be:

• Texas-based, for-profit companies (or willing to relocate)

• Able to meet Texas presence requirements (e.g., HQ, personnel, manufacturing, or clinical activity in Texas)

• Compliant with CPRIT eligibility rules

What companies and projects are likely to win?

• Address a significant unmet medical need

• Demonstrate strong technical validation

• Show a clear path to commercialization

• Have an experienced management team

• Present a credible regulatory and development strategy

Are there any restrictions I should know about?

• Must maintain a business presence in Texas or be willing to relocate to Texas upon selection for award

• Matching funds are required

• Indirect costs capped at ~5%

• Travel expenses are not reimbursable (can count as matching funds)

• Funding is milestone-based with reporting requirements

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($20,000 + 5%) available (Only $5,000 for preliminary application).

Additional Resources

Review the solicitation here.

NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research - Naval Research Laboratory (NRL)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Naval Research Laboratory (NRL) is seeking innovative basic and applied research proposals across a wide range of scientific and engineering disciplines. Organizations can submit White Papers through September 30, 2026, with potential follow-on contracts, grants, or other agreements awarded based on technical merit.

How much funding would I receive?

Est. $500k to $5 million.

What could I use the funding for?

Funding supports basic and applied research aligned with Navy priorities, including (verbatim/high-level categories from the BAA):

• Systems Directorate (e.g., radar, antennas, computational electromagnetics, information systems, AI/ML, human systems integration)

• Materials Science and Component Technology (e.g., energy storage, corrosion, materials processing, bio/chemical detection)

• Ocean and Atmospheric Science (e.g., ocean acoustics, remote sensing, environmental modeling)

• Space Technology (e.g., spacecraft systems, sensors, propulsion, hypersonics)

Specific topic areas include (selected verbatim examples):

• “Virtual simulations and mixed reality systems… situational awareness, and training”

• “Data management and exploitation technologies that apply emerging mathematics and machine learning techniques”

• “Multi-agent and multi-robot systems, reinforcement learning, game theory”

• “Electrochemical energy storage and conversion systems such as batteries and fuel cells”

• “Optical sciences… lasers, sensors, and photonic technologies”

• “Cyber security, cryptographic technologies, and high assurance computing”

• “Spacecraft payloads; spacecraft propulsion systems; advanced materials for spaceflight use”

Many More Topics are listed in the Solicitation (See below).

Are there any additional benefits I would receive?

Beyond the formal funding award, there are significant indirect benefits:

Government Validation and Credibility:
Being selected by the Naval Research Laboratory signals strong technical credibility and alignment with U.S. Navy and DoD priorities.

Access to Defense Ecosystem:
Awardees gain exposure to Navy researchers, program managers, and potential transition partners across defense and aerospace.

Flexible Contracting Pathways:
The BAA allows for multiple award mechanisms (contracts, grants, OTAs), enabling faster and more flexible engagement than traditional procurement.

Follow-On Funding Opportunities:
Successful projects may lead to additional funding phases or expanded research programs based on performance.

Increased Strategic Positioning:
Participation positions companies for future DoD funding, partnerships, and potential acquisition interest.

What is the timeline to apply and when would I receive funding?

• White Papers Due: September 30, 2026 (4:00 PM EDT)

• Rolling evaluation and invitation for full proposals after White Paper review

• Funding timing varies based on evaluation and award negotiations

Where does this funding come from?

Department of Defense (DoD) → Department of the Navy → Office of Naval Research (ONR) → Naval Research Laboratory (NRL)

Who is eligible to apply?

• Educational institutions

• Small businesses

• Small disadvantaged businesses

• Historically Black Colleges and Universities (HBCUs)

• Minority institutions

• Other qualified organizations

What companies and projects are likely to win?

Selections are based on:

• Technical merit and scientific quality of the proposed approach

• Relevance to NRL research priorities

• Potential benefit to the Government relative to cost

• Feasibility and innovation of the solution

• Cost realism and overall value

Are there any restrictions I should know about?

• Must submit a White Paper first before a full proposal

• Some topics may require security clearances or classified work

• Awards depend on availability of funding

• Government may select all, some, or none of proposals

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

Small UAS & Asymmetric Capabilities CSO Call 001 - Department of the Air Force

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The U.S. Air Force is soliciting innovative commercial solutions for small unmanned aircraft systems (sUAS) to support asymmetric warfare missions. Awards may be issued as FAR-based contracts or Other Transaction (OT) prototype agreements, with potential follow-on production. Phase 1 submissions are due April 20, 2026.

How much funding would I receive?

Est. $500k to $5 million.

What could I use the funding for?

Funding is intended to develop short-range, one-way attack UAS platforms with the following characteristics:

• Operate at ranges 50+ nautical miles

• Speeds exceeding 200 mph

• Ground-launched, containerized for mass deployment

• Fire-and-forget autonomy with in-flight targeting

• Coordination with other platforms

• Operation in denied, degraded, intermittent, or low-bandwidth (DDIL) environments

• Beyond line-of-sight (BLOS) capability

• Low observability

Additional required areas:

• Mission planning software integration

• Modular hardware/software with open interfaces

• Passive sensing capabilities (RF, EO/IR, acoustic, etc.)

• Scalable manufacturing and production plans

• Training and operational deployment concepts

Are there any additional benefits I would receive?

Beyond the formal funding award, there are significant indirect benefits:

Government Validation and Credibility: Selection by the U.S. Air Force signals strong technical credibility and alignment with national defense priorities, increasing trust with primes, investors, and partners.

Follow-on Production Opportunities: Successful prototype projects under OT authority may lead directly to production contracts without further competition.

Enhanced Market Visibility: Participation positions your company within the defense innovation ecosystem and may lead to additional DoD opportunities.

Ecosystem Access: Engagement with Air Force stakeholders and integration into operational environments can unlock future contracts and partnerships.

Stronger Exit Potential: Demonstrating operational capability under government funding can significantly increase valuation and acquisition interest.

What is the timeline to apply and when would I receive funding?

• Phase 1 Solution Brief Deadline: April 20, 2026

• Phase 2 Pitch Sessions: April 21 – April 28, 2026

• Phase 3 Proposals: By invitation only (date provided after Phase 2)

• Funding Timing: Not explicitly stated; occurs after Phase 3 award decisions

Where does this funding come from?

Department of Defense (DoD), specifically:

• Department of the Air Force

• Air Force Life Cycle Management Center (AFLCMC)

Who is eligible to apply?

• Open to U.S. and international vendors

• Companies must register in SAM.gov if selected

• Must be able to meet potential security clearance requirements (up to SECRET for later phases)

What companies and projects are likely to win?

• Demonstrate technically credible, scalable UAS solutions

• Show ability to operate in DDIL and GNSS-denied environments

• Provide modular, open-architecture systems (no proprietary lock-in)

• Prove performance via testing data and reliability metrics

• Present clear production scalability and cost efficiency

Are there any restrictions I should know about?

• Must comply with:

  • FY2020 NDAA Section 848

  • FY2023 NDAA Section 817

  • 2024 American Security Drone Act

• Must pass DoD cybersecurity requirements (RMF)

• Proprietary interfaces requiring vendor lock-in are not permitted

• Potential requirement for facility and personnel security clearances (Phase 3+)

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

SAF/CDM Commercial Solutions Opening (CSO) – U.S. Department of the Air Force

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The U.S. Air Force is offering funding through a Commercial Solutions Opening (CSO) to support innovative commercial technologies and services that address defense-related capability gaps. Awards are made on a rolling basis through September 30, 2026, and require an initial white paper submission followed by an invited full proposal.

How much funding would I receive?

Funding varies significantly by project. There is:

• No fixed award size per project

• An estimated total program budget of ~$100M across all awards

• Awards may be incrementally funded and vary widely in scope, duration, and value

What could I use the funding for?

Funding supports innovative commercial items, technologies, and services aligned with Air Force mission needs, including:

• Big Data, Artificial Intelligence and Machine Learning (AI/ML), technologies and processes

• Emerging cyber technologies and methodologies

• Countering strategic competitors’ malign influence

Are there any additional benefits I would receive?

Beyond funding, this opportunity offers meaningful strategic advantages:

• Government Validation and Credibility:
  Winning a U.S. Air Force award signals strong technical credibility and alignment with national defense priorities, which can accelerate partnerships with primes, integrators, and federal customers.

• Enhanced Market Visibility and Notoriety:
  Awardees gain exposure within DoD ecosystems and innovation networks, positioning the company as a trusted provider of mission-critical technology.

• Follow-on Contract Opportunities:
  Successful prototype efforts may lead to follow-on production contracts or expanded agreements without further competition.

• Stronger Exit and Acquisition Potential:
  Demonstrating validated DoD use cases and maturing technology with nondilutive funding can significantly increase enterprise value and acquisition attractiveness.

What is the timeline to apply and when would I receive funding?

• White papers can be submitted on a rolling basis until August 15, 2026

• Full proposals are submitted only upon government invitation

• Awards may be issued at any time through September 30, 2026

Where does this funding come from?

This funding comes from the U.S. Department of Defense, specifically the Department of the Air Force, under the Defense Commercial Solutions Opening Pilot Program authorized by Congress.

Who is eligible to apply?

• Open to all organizations capable of delivering innovative solutions, including:

  • Startups

  • Small businesses

  • Non-traditional defense contractors

  • Large enterprises

• Foreign participation is permitted, subject to security requirements

What companies and projects are likely to win?

• Demonstrate breakthrough innovation rather than incremental improvements

• Address critical or urgent Department of Defense needs

• Show strong technical feasibility and a clear execution plan

• Align with Air Force mission priorities and capability gaps

• Provide pricing that is fair and reasonable

Are there any restrictions I should know about?

• A White Paper is required before submitting a full proposal

• Full proposals are by invitation only

• Must comply with DoD security requirements and classification guidelines

• Export control regulations (ITAR/EAR) may apply

• Conflict of interest rules apply for certain contractors

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

1. Triple your likelihood of success through proven strategy and insider-aligned proposal development

2. Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

3. Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

FAA - BROAD AGENCY ANNOUNCEMENT AVIATION RESEARCH 2025

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

This FAA Broad Agency Announcement (BAA) is an open, rolling opportunity to submit white papers for aviation research topics. There is no fixed deadline—white papers may be submitted at any time until the expiration of the BAA or until a Topic is removed.

If you are developing technologies in airport pavements, aircraft structures, propulsion, avionics, AI/ML, or safety systems, this is a flexible entry point to secure non-dilutive R&D funding. Because submissions are accepted on a rolling basis, strong teams can engage early and iterate with the FAA.

How much funding would I receive?

Funding varies by topic. Examples explicitly stated include:

• Many topics:

  • Not to exceed $200,000.00 per project, per fiscal year

• Some topics:

  • Approximately $250,000 per project, per fiscal year

  • Approximately $350,000 (total)

  • Not to exceed $400,000.00 per project, per fiscal year

• In several topics:

  • Funding is not specified and will be determined based on the proposed work

All funding is:

• Subject to availability

• Typically awarded annually

What could I use the funding for?

Funding supports aviation R&D aligned with FAA priorities, including:

• Airport pavement research (e.g., cracking, materials, instrumentation, modeling)

• Structural integrity of aircraft components

• Propulsion and fatigue testing (e.g., nickel alloy anomalies)

• Flight controls, avionics, and safety systems

• AI/ML applications in aviation systems and certification

• Software tools and engineering models (e.g., FAARFIELD, BAKFAA)

• Oversight systems, safety management, and regulatory innovation

Projects generally include:

• Research, testing, and data analysis

• Modeling and simulation

• Software/tool development

• Field validation and implementation planning‍ ‍

Are there any additional benefits I would receive?

• Direct engagement with FAA technical teams and subject matter experts

• Opportunity to influence FAA standards, Advisory Circulars, and software tools

• Access to FAA datasets, test facilities (e.g., NAPTF), and research infrastructure (where applicable)

• Potential for follow-on work based on performance and results

What is the timeline to apply and when would I receive funding?

• Submission timeline:

  • White papers may be submitted at any time until the expiration of the BAA or until the Topic is removed

• Project duration:

  • Many topics allow up to 3 years

  • Some specify 12 to 36 months or 24 months

  • Others: not specified

• Funding cadence:

  • Typically annual funding, subject to availability

  • Continued funding is at FAA discretion based on performance and results

• Award timing:

  • Not specified in the solicitation

Where does this funding come from?

• Federal Aviation Administration (FAA)

• Specifically through the William J. Hughes Technical Center for Advanced Aerospace

This is a Broad Agency Announcement (BAA) for aviation research.

Who is eligible to apply?

• Eligibility is not explicitly specified in the provided text

The solicitation refers broadly to:

• “Offerors”

• “Aviation community”

• Entities capable of submitting white papers aligned to technical topics

What companies and projects are likely to win?

Based on the solicitation, competitive projects will:

• Directly address a specific Topic of Interest

• Demonstrate technical feasibility and research rigor

• Leverage real-world data, FAA datasets, or test facilities

• Align with FAA implementation goals (e.g., integration into FAARFIELD, Advisory Circulars)

• Show clear pathways to improving safety, performance, or certification processes

• Incorporate advanced methods (e.g., AI/ML, modeling, novel instrumentation) where relevant

Projects that connect research outputs to practical FAA use cases are strongly aligned.

Are there any restrictions I should know about?

• Submissions must be in the form of white papers aligned to specific Topics

• Work must follow instructions and evaluation criteria in the BAA

• Some topics include specific constraints, for example:

  • Avoiding proprietary system promotion in certain research areas

  • Compatibility with FAA systems or software environments

• Funding is:

  • Subject to availability

  • At FAA discretion based on performance and results

No universal restrictions (e.g., cost share, TRLs) are specified in the provided text.

How long will it take me to prepare an application?

• The solicitation requires brief descriptive white papers

Estimated effort will depend on complexity, but:

• White papers are typically faster to prepare than full proposals

• Exact preparation time is not specified in the solicitation

How can BW&CO help?

BW&CO can:

• Identify the best-fit FAA Topic(s) for your technology

• Translate your innovation into a compliant white paper aligned to FAA expectations

• Position your work for implementation into FAA standards, software, or guidance

• Help structure a phased engagement strategy to maximize follow-on funding

• Ensure your submission is clear, technically credible, and aligned with evaluation criteria

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

DIU: Robotic Exclusion & Engagement Framework (REEF)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Robotic Exclusion & Engagement Framework (REEF) is a bilateral U.S.–UK Commercial Solutions Opening (CSO) seeking technologies to detect, track, classify, and defeat underwater threats such as AUVs, UUVs, and semi-submersibles targeting ports and critical waterways. Solutions can address individual components or provide a full system, with preference for approaches that can integrate into a broader REEF architecture.

Selected vendors will work directly with U.S. and UK government teams and must be prepared to integrate and conduct in-water testing within 90 days of award.

Application deadline: 2026-04-03 23:59:59 US/Eastern Time.

How much funding would I receive?

Not specified in the solicitation, but typically will lead to awards between $500k - $2m.

What could I use the funding for?

Funding supports development and demonstration across four REEF components:

1. Detect, Track, and Classify

• Subsea detection (bearing, range, tracking data)

• Multi-sensor tracking and classification (including AI/ML)

• False alarm and clutter reduction

• Sensors (e.g., sonar, EO/IR, acoustic, magnetic, fiber optic sensing)

• Deployable fixed and mobile systems (USVs, UUVs, UAVs, buoys)

• Open architecture, MOSA-compliant systems

2. Defeat Capabilities

• Non-kinetic: nets, barriers, bubble curtains

• Kinetic: payloads, directed energy, physical disruption

• Decoy systems

3. Data and Network Architecture

• Secure, near real-time data transmission

• Encrypted systems compliant with DoD interfaces

4. COP/C2 (Command and Control)

• Common Operating Picture integration or standalone tools

• AI/ML decision support

• Multi-modal sensor fusion (AIS, radar, RF, acoustic, EO)

Are there any additional benefits I would receive?

• Direct path to follow-on production without further competition under 10 U.S.C. 4022(f)

• Opportunity for adoption across multiple DoD organizations

• Collaboration with U.S. and UK government teams

• Participation in technical development sessions

• Integration into a broader multi-vendor system

What is the timeline to apply and when would I receive funding?

• Application deadline: 2026-04-03 23:59:59 US/Eastern Time

Post-award requirements:

• Participate in several week-long technical development sessions

• Be ready for:

  • Integration with other systems within 90 days of Other Transaction award

  • In-water testing within that same timeframe

Where does this funding come from?

• Commercial companies

• U.S. and UK

• Non-U.S. companies may apply, subject to export control compliance

Additional requirements:

• Only one submission per vendor

• Must clearly identify which REEF component(s) the solution addresses

Who is eligible to apply?

• All sources capable of addressing the objectives of this CSO are eligible

Additional requirements:

• Must comply with security requirements (including DoD classification guidance)

• Must be able to operate in DoD cloud environments (IL5 with scalability to IL6)

What companies and projects are likely to win?

The government indicates preference for solutions that:

• Show a credible path to a full REEF system

• Are modular, scalable, and rapidly deployable

• Comply with open architecture (MOSA)

• Support the full Detect–Track–Classify–Defeat chain

• Perform reliably in complex maritime environments

• Can integrate with other vendors and systems

Both component-level and end-to-end solutions are encouraged.

Are there any restrictions I should know about?

• Export Controls:

  • U.S. EAR and ITAR provisions apply (with UK-specific exemptions)

  • UK companies may use General Export Authorisation No. 001

  • Non-U.S. companies must comply with home-nation export laws

• Submission limits:

  • Maximum 15 slides or 5-page whitepaper

  • Only one submission per vendor

• Collaboration requirement:

  • Vendors must work with other vendors and government partners

How long will it take me to prepare an application?

• Based on requirements:

  • A 15-slide or 5-page submission

  • Clear mapping to REEF components

This is structured for rapid preparation, especially for teams with existing technology.

How can BW&CO help?

• Identify the strongest REEF component fit for your solution

• Position your offering for system-level integration

• Translate capabilities into clear defense outcomes

• Ensure compliance with CSO format and evaluator expectations

• Build a concise, high-impact submission (slides or whitepaper)

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($9,000 + 5%) available.

Additional Resources

Review the solicitation here.

U.S. Navy NSWC Crane - MOBILITY PROTOTYPING

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

This is a U.S. Navy NSWC Crane multi-award IDIQ contract (Mobility MAC Follow-On, N0016426RMP01) to develop and test vehicle mobility prototypes across four technical areas (powertrain, chassis, testing, and integration).

You are not bidding on a single project—you are competing to get on-contract, after which you can compete for individual funded delivery orders.

Deadline: 11 May 2026, 02:00 PM local time

This is a high-value, long-term vehicle prototyping contract with access to DoD customers including USSOCOM and multiple services. If you are a mobility, automotive, or defense engineering company, this is a strategic contract vehicle to secure.

How much funding would I receive?

Funding is not guaranteed upfront beyond a minimum. Instead, funding is awarded through delivery orders after contract award.

• Minimum guarantee: $1,000

• Maximum per order: $25,000,000

• Contract structure: Multi-Award IDIQ (you compete for task orders after award)

The total contract ceiling and number of awards are not specified in the provided sections.

What could I use the funding for?

Funding is used to design, prototype, fabricate, and test mobility systems and components for military vehicles.

Four Technology Areas:

1. Powertrain Performance Prototyping

   • Engines, transmissions, hybrid systems, power generation, fuel economy improvements

2. Advanced Chassis, Body, and Mobility Handling

   • Suspension, steering, survivability, payload, vehicle structure

3. Mobility Testing Services

   • Full vehicle/system testing, durability, environmental, and performance validation

4. General Prototype Fabrication and Integration

   • Building and integrating physical prototypes from designs

Work may include:

• Engineering design, CAD/CAE, and simulations

• Prototype fabrication and integration

• Testing and evaluation (including armor and environmental testing)

• Technical data packages and reports

• Transition to Low-Rate Initial Production (LRIP)

Are there any additional benefits I would receive?

Yes—this is a strategic contract vehicle, not just a grant.

• Access to recurring delivery orders over a 5-year contract period

• Ability to work with:

  • USSOCOM

  • U.S. Army, Navy, Air Force, Marine Corps

  • Combatant Commands (CENTCOM, PACOM, etc.)

• Opportunity to:

  • Transition prototypes into production (LRIP)

  • Influence future mobility platforms

• Rolling admissions may allow additional contractors to be added later (limited to small businesses)

What is the timeline to apply and when would I receive funding?

• Solicitation issued: 19 Mar 2026

• Application deadline: 11 May 2026, 02:00 PM local time

After award:

• You must compete for delivery orders (DOs)

• Each DO will include:

  • Statement of Objectives (SOO)

  • Technical requirements, schedule, and funding

• Funding is received only when you win individual DO competitions

Specific award timing and first funding timeline are not specified in the solicitation.

Where does this funding come from?

• U.S. Navy – Naval Surface Warfare Center (NSWC) Crane

• Supporting broader Department of Defense mobility and vehicle modernization efforts

Who is eligible to apply?

The solicitation refers to “interested vendors” that can demonstrate capability in one or more Technology Areas.

You must:

• Propose capabilities in one or more Technology Areas

• Provide historical documentation and current capabilities

• Be able to perform engineering, prototyping, testing, and integration work

Additional eligibility constraints:

• Must comply with ITAR and export control restrictions

• Work must remain under U.S. control (no foreign involvement without approval)

Small business set-asides may apply at the delivery order level, but overall eligibility categories are not fully specified.

What companies and projects are likely to win?

Winners will be companies that demonstrate:

• Strong technical capability in at least one Technology Area

• Proven experience in:

  • Mobility systems engineering

  • Automotive or defense prototyping

  • Testing and validation

• Ability to:

  • Deliver end-to-end prototype development

  • Transition designs toward production

At the delivery order level, proposals are evaluated on:

• Technical approach (most important)

• Schedule

• Past performance

• Price (least important unless proposals are similar)

Are there any restrictions I should know about?

Yes—this is a highly regulated DoD contract.

Key restrictions include:

• ITAR / export control compliance required

• No foreign nationals, facilities, or suppliers without approval

• Government retains data rights for developed work

• Strict:

  • Quality standards (ISO/ANSI requirements)

  • Testing standards (MIL-STD, SAE, etc.)

• Organizational Conflict of Interest (OCI) rules may limit future work

• Security and handling requirements for sensitive data and equipment

How long will it take me to prepare an application?

Based on requirements, expect significant effort to:

• Document past performance and capabilities by Technology Area

• Prepare a technical proposal demonstrating engineering depth

• Align with DoD standards and compliance requirements

How can BW&CO help?

BW&CO can support you by:

• Positioning your company for multi-award IDIQ selection

• Structuring your proposal to align with:

  • Technology Area requirements

  • DoD evaluation criteria

• Developing:

  • Technical narratives

  • Past performance framing

  • Compliance and risk positioning

• Preparing you for delivery order competitions post-award

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($9,000 + 5%) available.

Additional Resources

Review the solicitation here.

Ground Vehicle System Center (GVSC) Commercial Solutions Opening (CSO)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The U.S. Army DEVCOM Ground Vehicle Systems Center (GVSC) is seeking innovative commercial technologies to support next-generation ground vehicle systems through a Commercial Solutions Opening (CSO). This is a rolling, multi-phase opportunity covering a wide range of Areas of Interest (AoIs), including power systems, autonomy, survivability, robotics, logistics, and advanced manufacturing.

Critical deadline: The “Durable Replacement Track System for M88A2 Vehicle” AoI deadline has been extended to 06 April 2026.

Most other AoIs are open on a continuous basis unless a specific suspense date is listed, meaning companies can submit at any time—but priority is given to time-sensitive topics.

This is a flexible, non-traditional DoD contracting pathway designed to move quickly from concept to award, including pilots, prototypes, and commercially ready solutions.

How much funding would I receive?

Not specified in the solicitation, but typically between $500k - $2m.

The CSO explicitly states that:

• “no specific dollars have been reserved for awards”

• awards are subject to availability of government funds

What could I use the funding for?

Funding can support development, demonstration, and deployment of innovative commercial technologies relevant to Army ground vehicle systems.

Examples across AoIs include:

• Power generation, propulsion, and energy systems

• Autonomous systems and robotics

• AI/ML-enabled vehicle capabilities

• Cybersecurity and software systems

• Logistics, maintenance, and supply chain technologies

• Advanced manufacturing and materials

• Vehicle survivability and protection systems

• Modeling, simulation, and training systems

Projects may include:

• Commercial technologies already available

• Adaptations of existing commercial products

• Concept demonstrations and pilots

• Incremental improvements to existing systems

Are there any additional benefits I would receive?

• Access to multiple award pathways, including:

  • FAR Part 12 contracts

  • Other Transaction Agreements (10 U.S.C. 4022)

  • Cooperative Agreements

• Ability to work directly with Army technical teams

• Opportunity for follow-on awards and scaling

• Flexible contracting with potential for industry-standard terms

• Potential to establish long-term partnerships with GVSC

What is the timeline to apply and when would I receive funding?

Application timeline:

• The CSO is open through 2029 unless extended

• Most AoIs are continuously open unless a specific deadline is listed

• Example:

  • Durable Replacement Track System for M88A2 Vehicle: 06 April 2026

Process timeline:

• Phase 1: Solution Brief submission

• Phase 2: Presentation (if invited)

• Phase 3: Full proposal (CSP)

Additional timing details:

• Presentations remain valid for 90 days

• CSP proposals must be valid for 180 days

• Awards occur only if funding becomes available

The Government may move quickly through phases if priorities are urgent.

Where does this funding come from?

Funding comes from the U.S. Army DEVCOM Ground Vehicle Systems Center (GVSC) under the authority of:

• 10 U.S.C. 3458 (Commercial Solutions Opening authority)

• Other DoD acquisition authorities including 10 U.S.C. 4022

GVSC operates under the U.S. Army Futures Command (AFC).

Who is eligible to apply?

The solicitation does not restrict eligibility to a specific entity type. Eligible participants may include:

• Commercial companies

• Small businesses

• Nontraditional defense contractors

• Nonprofits

• Foreign-owned companies (subject to approvals and clearances)

To receive an award, companies must:

• Have a Unique Entity ID (UEI)

• Be registered in SAM.gov

• Not be suspended or debarred

What companies and projects are likely to win?

Projects are evaluated based on:

• Relevance to the specific AoI

• Technical merit and feasibility

• Level of innovation

• Commercial readiness or near-term applicability

• Risk (technical, schedule, pricing)

• Availability of funding

Priority is placed on:

• Commercially available or near-term solutions

• Technologies that can be demonstrated quickly

• Solutions aligned with Army modernization priorities

• High-TRL technologies with clear transition pathways

Are there any restrictions I should know about?

Key restrictions include:

• No reimbursement for proposal or solution brief preparation costs

• Submissions must be unclassified

• Export-controlled data may require approvals

• Awards are not guaranteed, even after proposal submission

• Government may:

  • Skip phases

  • Cancel opportunities

  • Award to all, some, or none of applicants

Additional constraints:

• Typical period of performance is generally no greater than 12 months unless otherwise specified

• Intellectual property terms may be negotiated

How long will it take me to prepare an application?

Initial submission (Phase 1):

• Solution brief: up to 5 pages or 15 slides

This is relatively lightweight and can typically be prepared quickly.

Later phases (if invited):

• Presentation (Phase 2)

• Full proposal with technical and pricing volumes (Phase 3)

Effort increases significantly in Phase 3 depending on project complexity.

How can BW&CO help?

BW&CO can:

• Identify the right AoI for your technology

• Position your solution for maximum relevance and competitiveness

• Develop a high-impact solution brief aligned with evaluation criteria

• Support Phase 2 presentations and Phase 3 proposals

• Help structure pricing and commercialization strategy

• Navigate DoD contracting pathways and compliance requirements

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

DevX Autonomy: Open Call Solicitation for Innovative AUS Solutions

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Army Applications Laboratory (AAL) is accepting submissions for the Open Call Solicitation for Innovative AUS Solutions (W911NF-26-S-0040). This is a continuously open opportunity to get your autonomy or unmanned system solution into a government-facing platform that enables award without further competition if deemed “award-ready.”

This is not a traditional grant cycle. Instead, submissions are evaluated monthly, and strong solutions can move directly into contracting pathways. The open call runs from 30 December 2025 – 31 August 2026, with monthly submission cutoffs at 12:00 (Noon) Eastern Standard Time (EST) on the final day of each monthly collection period. Founders should treat each month-end deadline as a real submission opportunity.

How much funding would I receive?

• Not specified in the solicitation, but typically between $500k - $2m.

• No fixed award size, range, or ceiling is provided.

• Pricing is determined later through negotiation prior to award.

What could I use the funding for?

The solicitation is seeking autonomy and unmanned systems (AUS) solutions across hardware, software, and services. Specific focus areas include:

• Autonomous platforms (air, ground, maritime)

• Payloads (sensors, communications, effectors)

• Mission-enabling software/hardware

• Lethal capabilities

• Sustainment solutions (maintenance, fueling, deployment)

• Subcomponents (motors, sensors, controllers)

• Other disruptive autonomy solutions

Solutions may support:

• Research and development

• Prototyping

• Testing and evaluation

• Production and fielding

• Sustainment

Are there any additional benefits I would receive?

Key benefits include:

• Eligibility for future awards without further competition if deemed award-ready

• Direct visibility to U.S. Government stakeholders

• Feedback from Government Subject Matter Experts

• Opportunity for multiple awards per submission

• Access to rapid acquisition pathways

• Simplified submission process (short video + form)

What is the timeline to apply and when would I receive funding?

• Open call period: 30 December 2025 – 31 August 2026

• Submissions are accepted continuously

• Monthly deadlines:

  • 12:00 (Noon) Eastern Standard Time (EST) on the final day of each monthly collection period

• Review timeline:

  • Submissions are assessed in the following month

  • Results provided within 30 days after the end of the collection period

Funding timeline:

• Not specified in the solicitation

• Awards occur after selection and negotiation of terms

Where does this funding come from?

• U.S. Army Applications Laboratory (AAL)

• Under the U.S. Army Contracting Command, Aberdeen Proving Ground, Research Triangle Park Division

Authorities cited include:

• 10 USC 4021, 4022, 3458

• FAR Part 35

• DFARS Part 235 and Subpart 212.70

Who is eligible to apply?

Eligible applicants include:

• U.S.-based companies (large and small)

• Traditional and nontraditional defense contractors

• Universities

• Nonprofits and research institutions

• Individual developers

• Foreign entities (if compliant with applicable laws and export controls)

What companies and projects are likely to win?

Solutions are evaluated based on:

• Technical merit

• Technical approach and alignment with Army needs

• Company and team qualifications

• Clear definition of the problem

Higher likelihood of success if your solution:

• Clearly solves a meaningful government problem

• Demonstrates strong technical credibility

• Aligns with Army priorities (open, scalable, supportable, repairable systems)

• Shows real-world applicability or a clear path to maturity

• Includes a compelling demonstration (especially for higher TRLs)

Final “award-ready” decisions are made by a Government Selecting Official (GSO) after peer review.

Are there any restrictions I should know about?

Key constraints include:

• Submissions must be:

  • Unclassified

  • Free of proprietary, export-controlled, or CUI content

• Videos must:

  • Be ≤ 6 minutes

  • Meet strict formatting requirements

• All submission costs are not reimbursed

• Being deemed “award-ready” does not guarantee funding

• Government receives broad license rights to use submitted materials

• Only one solution per video submission

How long will it take me to prepare an application?

The submission consists of:

• A ≤ 6-minute video pitch

• A structured submission form with company, technical, and solution details

This is significantly lighter than traditional proposals, but requires:

• Clear messaging

• Strong technical explanation

• Demonstrated alignment with Army needs

How can BW&CO help?

BW&CO can:

• Translate your technology into a compelling 6-minute video script

• Position your solution against DevX evaluation criteria

• Align your messaging with Army priorities and focus areas

• Help structure your submission to maximize “award-ready” likelihood

• Prepare you for resubmissions using assessor feedback

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

CDMRP: Parkinson’s Research Program (PRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Parkinson’s Research Program (PRP) will fund innovative, high-impact research aimed at reducing risk, slowing progression, or easing symptoms of Parkinson’s disease. This is a pre-announcement, meaning you have time to prepare—but deadlines have not yet been released. Once funding opportunities are posted on Grants.gov, both pre-application and full application deadlines will be specified. Early preparation is critical to compete.

How much funding would I receive?

Funding depends on the award mechanism:

Early Investigator Research Award

• Funding Level 1:

  • Up to $300,000 total costs

  • Period of performance: 2 years

• Funding Level 2:

  • Up to $1,000,000 total costs

  • Period of performance: 2 years

Investigator-Initiated Research Award

• Up to $2,000,000 total costs

• Period of performance: 3 years

Total costs include direct and indirect costs.

What could I use the funding for?

Funding supports Parkinson’s disease research aligned to one or more of the following focus areas:

• Disease heterogeneity and its impact on progression and outcomes

• Advanced in vitro model systems that reflect in vivo complexity

• Biomarkers and biological mechanisms tied to unmet medical needs

• Research addressing:

  • Non-motor symptoms (e.g., cognitive, sleep, psychiatric, pain)

  • Motor symptoms (e.g., tremor, gait, dyskinesia)

• Development and testing of interventions, including:

  • Biological, pharmacological, and non-pharmacological approaches

  • Surgical and non-surgical devices

  • Non-invasive CNS stimulation

Projects may range from laboratory models to studies involving human participants, depending on the mechanism.

Are there any additional benefits I would receive?

• Opportunity to work within a Department of Defense-funded research program

• Access to a program prioritizing clinically relevant, high-impact outcomes

• Optional Partnering PI structure (Investigator-Initiated Research Award) to support collaboration between two investigators

• Structured support for early-career researchers, including mentorship (for Funding Level 1)

What is the timeline to apply and when would I receive funding?

• This is a pre-announcement; application deadlines are not yet specified

• Funding opportunity announcements will be posted on Grants.gov

• A pre-application is required via eBRAP before full submission

• Exact pre-application and full application deadlines will be included in the official announcements

Where does this funding come from?

• FY26 Defense Appropriations Act

• Managed by the Congressionally Directed Medical Research Programs (CDMRP)

• Under the Defense Health Agency Research and Development – Medical Research and Development Command (DHA R&D-MRDC)

Who is eligible to apply?

Early Investigator Research Award

• Postdoctoral fellows, clinical fellows, or independent investigators within 10 years of degree or residency completion

• Eligibility must be verified via an institutional statement

Investigator-Initiated Research Award

• Independent investigators at all academic levels, or equivalent

What companies and projects are likely to win?

Competitive applications will:

• Address one or more of the specified focus areas

• Demonstrate high-impact potential and clinical relevance

• Include:

  • Strong mentorship and career development (early investigators)

  • Preliminary data where required

  • Rigorous, multidisciplinary approaches (Investigator-Initiated Research Award)

• Target unmet medical needs in Parkinson’s disease, especially across motor and non-motor symptoms

Are there any restrictions I should know about?

Early Investigator Research Award

• Clinical trials are not allowed

• Mentorship is required for Funding Level 1

• Preliminary data:

  • Not required for Level 1

  • Required for Level 2

Investigator-Initiated Research Award

• Preliminary data are required

• Clinical trials are allowed

General

• Pre-application submission via eBRAP is required

• Applications must follow final instructions in the official funding announcements

How long will it take me to prepare an application?

• Not specified in the pre-announcement

• However, the requirement for a pre-application and full application, along with preliminary data (for most mechanisms), indicates a moderate to high preparation effort

How can BW&CO help?

BW&CO can support you by:

• Interpreting the full funding announcement once released

• Positioning your project against PRP focus areas and review criteria

• Developing a compelling technical narrative and commercialization angle

• Managing pre-application and full submission workflows

• Supporting teaming strategies, including Partnering PI structures

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

CDMRP: Duchenne Muscular Dystrophy Research Program (DMDRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Duchenne Muscular Dystrophy Research Program (DMDRP), managed by the Congressionally Directed Medical Research Programs (CDMRP), will fund high-impact research to improve function and quality of life for individuals with Duchenne muscular dystrophy (DMD). This is a pre-announcement, meaning application deadlines are not yet specified. Founders and investigators should begin preparing now ahead of the official release on Grants.gov, where deadlines will be published.

How much funding would I receive?

Two award mechanisms are anticipated:

Idea Development Award

• Maximum funding: $500,000 in total costs

• Period of performance: 2 years

Clinical/Translational Research Award

Funding Level 1

• Single PI: $910,000 in total costs

• Partnering PI Option: $1 million in total costs

• Period of performance: 3 years

Funding Level 2

• Single PI: $1.75M in total costs

• Partnering PI Option: $1.9M in total costs

• Period of performance: 4 years

Total costs include direct and indirect costs.

What could I use the funding for?

Idea Development Award

• High-risk/high-reward research advancing understanding of DMD

• Development of macromolecular and cellular therapies targeting primary pathology

• Research must include preliminary data

• Cannot fund clinical trials or clinical trial aims

Clinical/Translational Research Award

• Translational research with near-term clinical impact

• Preclinical work supporting IND-enabling studies

• Clinical research including:

  • Real-world data or post-market studies

  • Combination or sequential therapy studies

  • Long-term safety and efficacy studies

  • Studies to improve care and quality of life

  • Clinical trial tools and outcome measures

  • Natural history studies for trial readiness

• Can include clinical trials, pilot trials, and readiness studies

• Must include preliminary data

Are there any additional benefits I would receive?

• Access to CDMRP-managed funding programs within the Defense Health Agency Research and Development ecosystem

• Optional Partnering PI structure for Clinical/Translational Research Awards to support collaboration between investigators

What is the timeline to apply and when would I receive funding?

• This is a pre-announcement only

• Pre-application and full application deadlines are not specified

• Deadlines will be released with the official funding opportunity announcements on Grants.gov

• A pre-application submission through eBRAP is required prior to full application submission

Where does this funding come from?

• FY26 Defense Appropriations Act

• Managed by the Congressionally Directed Medical Research Programs (CDMRP)

• Under the Defense Health Agency Research and Development – Medical Research and Development Command (DHA R&D-MRDC)

Who is eligible to apply?

Idea Development Award

• Established independent investigators

• Early-stage investigators:

  • Within 10 years of first faculty appointment

  • Must not have previously received this award

• Transitioning investigators entering DMD from another field

• Must:

  • Be pursuing an active line of DMD research

  • Commit at least 10% effort annually

Clinical/Translational Research Award

• Independent investigators at all academic levels

• Optional Partnering PI must be:

  • Early-career (within 10 years), or

  • Established investigator from another field entering DMD

What companies and projects are likely to win?

• Projects focused on safe and effective macromolecular and cellular therapies addressing the primary pathology of DMD

• Research with clinical relevance and translational potential

• Studies that demonstrate impact across the lifespan, including:

  • Infants

  • Toddlers

  • Non-ambulatory individuals

• Applications supported by strong preliminary data

• High-risk/high-reward ideas (Idea Development Award) or near-term clinical impact (Clinical/Translational Award)

Are there any restrictions I should know about?

• Idea Development Award:

  • Cannot fund clinical trials or clinical trial aims

• All applications:

  • Must include preliminary data

  • Must align with specified focus areas

• Pre-application submission via eBRAP is required

• Applications must conform to final FOA requirements once released

How long will it take me to prepare an application?

• Not specified in the pre-announcement

• However, preparation should begin now given:

  • Required preliminary data

  • Mandatory pre-application step

  • Competitive, high-impact nature of the program

How can BW&CO help?

• Evaluate fit across Idea Development vs. Clinical/Translational tracks

• Shape your research into a CDMRP-aligned, reviewer-ready narrative

• Support Partnering PI strategy and positioning

• Develop compliant pre-applications and full submissions

• Maximize competitiveness for high-risk/high-reward and translational proposals

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

CDMRP: Pharmacotherapies for Alcohol and Substance Use Disorder Alliance (PASA)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

PASA has four live RFA 8 opportunities under the Study Research Planning Program (SRPP), and the first deadline comes fast: pre-applications are due 04/15/2026 across all four opportunities. Full applications are then due either 06/05/2026 or 06/17/2026 depending on the award type. In plain terms, this is a staged PASA funding cycle for teams working on drug discovery, pre-clinical animal research, human participant clinical trial planning, or expansion of previously funded PASA work. The planning award is for human participant clinical trial planning, the pre-clinical award is for animal research, the drug discovery award is for nonclinical discovery work, and the expansion award is only for current or previously funded PASA studies.

How much funding would I receive?

RFA 8a / Planning Award
Maximum Total Cost (Direct and Indirect): $150,000.
Period of Performance: 9-12 months.

RFA 8b / Pre-Clinical Award
The maximum total cost is not specified in the source materials I reviewed.
The period of performance is not specified in the source materials I reviewed.

RFA 8c / Drug Discovery Award
Maximum Total Cost (Direct and Indirect): $600,000.
Period of Performance: 24 months.

RFA 8d / Expansion Award
Maximum Total Cost (Direct and Indirect): $250,000-$750,000.
Period of Performance: 12-24 months.

What could I use the funding for?

RFA 8a / Planning Award
Use this for a specific compound or combination of compounds where you need a clinical implementation strategy to move toward FDA approval for ASUD treatment. PASA says the award supports development of a series of studies, the protocol for the first study, and related regulatory pathway work.

RFA 8b / Pre-Clinical Award
Use this for proof-of-principle pre-clinical animal research to determine which compounds are most appropriate for human research trials.

RFA 8c / Drug Discovery Award
Use this for proof-of-principle nonclinical drug discovery research to determine which compounds are most appropriate for later human research trials. The RFA says this can include computational-based analysis, including in silico and augmented intelligence research.

RFA 8d / Expansion Award
Use this only to continue or extend research that was previously funded by PASA. PASA says the expansion award may support drug discovery, pre-clinical, or clinical research, as long as it is the next step or an expansion on currently funded work.

Are there any additional benefits I would receive?

PASA says successful projects are conducted as part of PASA with PASA Management Core involvement. Across the RFAs, that support includes oversight and coordination, data repository functions, and analytic support. PASA’s support page also says PASA statisticians are available during proposal development to review or help develop power, sample size, and analytic plans, and that PASA-funded projects receive centralized management and statistical support after award.

For the Planning Award specifically, PASA says a productive award will yield a clinical implementation strategy, a protocol for the first study in the plan, and FDA approval or exemption for the plan and protocol.

What is the timeline to apply and when would I receive funding?

RFA 8a / Planning Award
Pre-application Due 04/15/2026.
Go/ No Go Response from PASA Management Core (for submission of full applications) 04/24/2026.
Full Application Due 06/05/2026.
Peer Review Process July 2026.
Consortium Steering Committee Review Mid-August 2026.
Notification of Award Recommendations August 2026.
Award Negotiations Begin September 2026.

RFA 8b / Pre-Clinical Award
Pre-application Due 04/15/2026.
Go/ No Go Response from PASA Management Core (for submission of full applications) 04/24/2026.
Full Application Due 06/17/2026.
Peer Review Process Ends July 2026.
Consortium Steering Committee Review Mid-August 2026.
Notification of Award Recommendations August 2026.
Award Negotiations Begin September 2026.

RFA 8c / Drug Discovery Award
Pre-application Due 04/15/2026.
Go/ No Go Response from PASA Management Core (for submission of full applications) 04/24/2026.
Full Application Due 06/17/2026.
Peer Review Process Ends July 2026.
Consortium Steering Committee Review Mid-August 2026.
Notification of Award Recommendations August 2026.
Award Negotiations Begin September 2026.

RFA 8d / Expansion Award
Pre-application Due 04/15/2026.
Go/ No Go Response from PASA Management Core (for submission of full applications) 04/24/2026.
Full Application Due 06/05/2026.
Peer Review Process Ends July 2026.
Consortium Steering Committee Review Mid-August 2026.
Notification of Award Recommendations August 2026.
Award Negotiations Begin September 2026.

The solicitations say award negotiations begin in September 2026. They do not specify an exact award date or disbursement date.

Where does this funding come from?

The solicitations and FAQ say PASA is funded by the Congressionally Directed Medical Research Programs (CDMRP) through the Alcohol and Substance Use Disorders Research Program (ASUDRP). The FAQ states PASA’s work is supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, managed by CDMRP under Awards W81XWH-15-2-0077, W81XWH-18-2-0044, W81XWH-22-2-0081 and HT94252520002.

Who is eligible to apply?

The FAQ says any institution can apply. It also says international submissions are allowed, more than one application from the same institution is allowed, and those applications are reviewed independently. Co-PIs are allowed. You do not need to already be associated with PASA to apply. For studies involving human participants, the FAQ says applications with Veteran’s Administration (VA) collaborators may be viewed more positively.

There is one major award-specific eligibility limit: RFA 8d / Expansion Award is only for current or previously funded PASA studies.

What companies and projects are likely to win?

The solicitations consistently favor projects that align closely with PASA’s goals and focus areas, address ASUD particularly but not limited to comorbid PTSD and other mental health conditions, and have strong potential to inform future clinical trials or improve pharmacotherapies.

• The strongest projects are likely to be those that:

  • show clear alignment with PASA strategic goals and focus areas;

  • present a strong research idea and clear impact;

  • demonstrate feasibility, appropriate budget, and strong team qualifications;

  • show how the work could support regulatory progression and future clinical trials; and

  • for planning awards and clinical work, show a path toward pharmaceutical collaboration or eventual marketing.

The FAQ says a commercial partnership is not required for funding, but for planning awards and clinical trials it is recommended, and a demonstrated relationship with a pharmaceutical company with a path to eventual marketing will be a factor in award selections.

For RFA 8d, the strongest projects are likely to be previously funded PASA studies that can clearly justify why the research is ready for the next phase and how the proposed work builds on prior PASA-funded results.

Are there any restrictions I should know about?

All four opportunities require a pre-application before a full application. PASA states that a “go” response from the PASA Management Core is required to proceed with the full application.

RFA 8d is limited to current or previously funded PASA work.

The FAQ says PASA RFA8 does not include the development and/or validation of animal models of disease.

For pre-clinical studies, PASA says most funded studies must be conducted in accordance with Good Laboratory Practice (GLP) requirements, though some basic science studies may not require GLP and PASA will make that determination in consultation with the PI.

For expansion awards, PASA says most studies must be conducted in accordance with GCP and/or GLP requirements.

Because PASA funding comes through CDMRP/ASUDRP, the solicitations say subaward funds will be subject to policies and restrictions based on that source of funding.

How long will it take me to prepare an application?

What is specified is the application structure. Each RFA requires a pre-application first, followed by a full application only if you receive a go decision. The pre-application is limited to four pages. Full applications then require multiple technical sections, budget materials, and supporting documentation. The planning award, pre-clinical award, drug discovery award, and expansion award each have different required components, so preparation time will depend on which RFA you target.

How can BW&CO help?

BW&CO can support across all phases of the CSO:

• Strategize the correct solicitation according to your project

• Help strategize on the nature and scope of the project

• Drafting the initial submission and managing the project of applying

• Increasing likelihood of success and saving time

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

U.S. Army Contracting Command – Anniston Army Depot (ACC-HDA)Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

This is a continuously open Commercial Solutions Opening (CSO) from the U.S. Army Contracting Command – Anniston Army Depot to fund innovative commercial technologies that modernize the Army’s Organic Industrial Base (OIB). The program is actively seeking solutions across advanced manufacturing, automation, digital enterprise, and related areas.

The CSO is continuously open until September 30, 2030. Companies can submit in response to specific Areas of Interest (AoIs) as they are released on SAM.gov, so timing depends on each AoI posting. Early engagement is strongly encouraged as the government can move quickly through evaluation phases.

How much funding would I receive?

• Not specified in the solicitation, but awards typically range from $500k to $5m.

  • Awards are dependent on specific AoIs and availability of government funds

  • Pricing is proposed by the company (starting with a rough order of magnitude in early phases)

  • Final award amounts are negotiated during the proposal phase

What could I use the funding for?

Funding is intended for innovative commercial technologies, products, and services that support modernization of Army depot operations.

Relevant use cases include:

• Advanced manufacturing and maintenance technologies

• Automation and robotics

• Digital enterprise systems (AI, IoT, cloud, 5G)

• Predictive maintenance and diagnostics

• Logistics and inventory modernization

• Process modernization (e.g., coatings, surface treatment)

• Workforce development systems

• Energy and environmental solutions

Solutions may include:

• Commercial technologies already available

• Adaptations of existing commercial products

• Pilot demonstrations or concept development efforts

Are there any additional benefits I would receive?

The CSO highlights several non-dilutive and strategic benefits:

• Streamlined application process with minimal initial requirements

• Negotiable payment terms (non-dilutive capital)

• Negotiable intellectual property (IP) rights

• Direct feedback from DoD end users and mission partners

• Fast-track evaluation timelines for early-stage submissions

• Each proposal evaluated on its own merits (not comparatively)

What is the timeline to apply and when would I receive funding?

• CSO open until: September 30, 2030

• AoIs are released separately and define specific submission windows

Typical process timeline:

• Phase 1 (Solution Brief): Government aims to evaluate within ~30 days after submission deadline

• Phase 2 (Pitch): Evaluation typically within ~30 days

• Phase 3 (Full Proposal): Timeline not specified

• Awards: Dependent on funding availability and negotiations

The government may accelerate or skip phases depending on urgency and proposal quality.

Where does this funding come from?

• U.S. Army Contracting Command – Anniston Army Depot (ACC-HDA)

• Authorized under:

  • Section 803 of the FY2022 National Defense Authorization Act

  • DFARS Subpart 212-70 (Commercial Solutions Opening authority)

Funding supports Department of Defense modernization priorities for the Organic Industrial Base.

Who is eligible to apply?

Eligible applicants include:

• Traditional defense contractors

• Nontraditional defense contractors

• Small businesses

• Nonprofit research institutions

• Foreign-owned companies (subject to clearance and approval requirements)

Additional requirements for award:

• Must obtain a Unique Entity ID (UEI)

• Must be registered in SAM.gov

• Must not be suspended or debarred from federal contracting

What companies and projects are likely to win?

Projects are evaluated based on:

• Alignment with specific AoI requirements

• Technical merit and feasibility

• Level of innovation and uniqueness

• Commercial readiness and ability to meet immediate needs

• Realistic pricing and schedule

• Company viability and risk profile

Solutions that demonstrate clear applicability to Army needs and strong commercial maturity are most competitive.

Are there any restrictions I should know about?

Key restrictions include:

• Submissions must be unclassified

• Proposal preparation costs are not reimbursable

• Solution briefs and pitches are generally unpaid

• Period of performance typically should not exceed 12 months (unless specified otherwise)

• Export-controlled technologies may require approvals

• Awards are subject to availability of funds

• The government may select all, some, or none of submissions

• Only a Contracting Officer can execute agreements

Additionally, submissions must follow AoI-specific instructions and deadlines to be considered.

How long will it take me to prepare an application?

• Phase 1 Solution Brief:

  • Up to 5 pages or 15 slides

  • Includes executive summary, technical concept, and rough pricing

Later phases (pitch and full proposal) require more detailed technical and pricing information.

Overall preparation time depends on the complexity of the solution and the phase reached.

How can BW&CO help?

BW&CO can support across all phases of the CSO:

• Identify and track relevant AoIs as they are released

• Develop high-impact solution briefs aligned to evaluation criteria

• Prepare pitch materials and messaging for Phase 2

• Build full Commercial Solution Proposals (CSPs)

• Support pricing strategy and negotiation positioning

• Ensure compliance with all CSO requirements

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($15,000 + 5%) available.

Additional Resources

Review the solicitation here.

DOE // The Genesis Mission: Transforming Science and Energy with AI (DE-FOA-0003612)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

This Department of Energy (DOE) funding opportunity—“The Genesis Mission: Transforming Science and Energy with AI” (DE-FOA-0003612)—is a large-scale, multi-agency initiative to fund interdisciplinary teams using AI to accelerate scientific discovery and energy innovation.

You can apply for FY26 Phase I by April 28, 2026, at 11:59 PM Eastern.

This is a high-priority federal AI + energy program with $293.76 million in total funding available, targeting sectors like advanced manufacturing, biotech, nuclear, fusion, semiconductors, and energy systems.

If you are building AI-enabled science or energy technology and can form a strong multi-institution team, this is a flagship opportunity with significant funding and long-term follow-on potential.

How much funding would I receive?

• Phase I: $500,000 to $750,000

• Phase II: Envisioned as 3 to 5 times the Phase I award

• Total program funding: ~$293.76 million

• Project duration:

  • Phase I: 9 months

  • Phase II: 3 years

• Number of awards: Not specified (depends on merit and available funds)

What could I use the funding for?

Funding supports R&D using AI models and frameworks to accelerate scientific discovery and energy systems innovation.

Eligible work includes:

• AI-driven scientific workflows and models

• Integration of AI with experimental and computational research

• Development of digital twins, simulations, and predictive models

• Automation of research, experimentation, and analysis

Topic areas include:

• Advanced manufacturing

• Biotechnology

• Critical materials

• Nuclear fission and fusion

• Quantum information science

• Semiconductors and microelectronics

• Energy systems and discovery science

Are there any additional benefits I would receive?

• Potential integration into the American Science Cloud (AmSC)

• Access to DOE/NNSA National Laboratories, datasets, and infrastructure

• Participation in the Genesis Mission ecosystem and consortium collaborations

• Opportunity for Phase II expansion (3–5x funding scale)

What is the timeline to apply and when would I receive funding?

Key deadlines:

• FY26 Phase I Applications: April 28, 2026, at 11:59 PM Eastern

• FY26 Phase II Letters of Intent: April 28, 2026, at 5 PM Eastern

• FY26 Phase II Applications: May 19, 2026, at 11:59 PM Eastern

• Phase II (from Phase I awards): December 17, 2026, at 11:59 PM Eastern

• Selection timing: Not specified in the solicitation

Where does this funding come from?

Funding comes from multiple DOE offices, including:

• Office of Science (SC)

• Office of Critical Minerals and Energy Innovation (CMEI)

• Office of Environmental Management (EM)

• Office of Electricity (OE)

• Office of Nuclear Energy (NE)

• Hydrocarbons and Geothermal Energy Office (HGEO)

Funding is issued using DOE’s Other Transaction Authority (OTA).

Who is eligible to apply?

• All types of domestic applicants (with exceptions noted below)

• DOE/NNSA National Laboratories

• FFRDCs and other federal agencies (with specific rules)

• Industry, universities, and nonprofits

Key requirements:

• Must form multi-institutional teams

• Phase I teams must include partners from at least two of three categories:

  • DOE/NNSA National Lab or user facility

  • Industry

  • IHE / nonprofit / other

What companies and projects are likely to win?

Competitive applications will:

• Demonstrate clear AI advantage in scientific or R&D workflows

• Show quantifiable improvements (e.g., predictive power, speed, automation)

• Leverage DOE data, infrastructure, or national lab capabilities

• Include strong interdisciplinary, multi-institution teams

• Align with one of the defined topic and focus areas

Phase I specifically favors:

• Proof-of-concept workflows

• Measurable indicators of future scalability and impact

Are there any restrictions I should know about?

• Cost share requirements:

  • Not required for most applicants

  • For-profit entities must provide:

    • ≥20% cost share for R&D

    • 50% for demonstration/commercial activities

• Teaming requirements are mandatory

• Limits on submissions:

  • One lead application per focus area per institution

• Restrictions on PI roles and institutional participation apply (as detailed in the solicitation)

• Applications may be declined without review if requirements are not met

How long will it take me to prepare an application?

Based on requirements:

• Multi-institutional coordination

• Technical proposal + budget + compliance documentation

Preparation will likely require significant coordination across partners (not quantified in the solicitation).

How can BW&CO help?

BW&CO can:

• Identify the best-fit topic and focus area

• Structure your multi-institution team strategy

• Translate your technology into DOE-aligned AI advantage narratives

• Develop a clear, competitive Phase I proposal

• Support partner coordination, budget strategy, and submission compliance

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.